DK0678027T3 - Antiatherosclerotiske midler - Google Patents

Antiatherosclerotiske midler

Info

Publication number
DK0678027T3
DK0678027T3 DK94906461T DK94906461T DK0678027T3 DK 0678027 T3 DK0678027 T3 DK 0678027T3 DK 94906461 T DK94906461 T DK 94906461T DK 94906461 T DK94906461 T DK 94906461T DK 0678027 T3 DK0678027 T3 DK 0678027T3
Authority
DK
Denmark
Prior art keywords
ester
dihydroequilin
alpha
sulfate
absence
Prior art date
Application number
DK94906461T
Other languages
Danish (da)
English (en)
Inventor
Steven Jay Adelman
Kurt Edric Steiner
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/157,661 external-priority patent/US5482935A/en
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of DK0678027T3 publication Critical patent/DK0678027T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DK94906461T 1993-01-05 1993-12-22 Antiatherosclerotiske midler DK0678027T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77793A 1993-01-05 1993-01-05
US08/157,661 US5482935A (en) 1993-01-05 1993-12-01 Anti-atherosclerotic use of 17 alpha-dihydroequilin
PCT/US1993/012559 WO1994015612A1 (en) 1993-01-05 1993-12-22 Anti-atherosclerotic agents

Publications (1)

Publication Number Publication Date
DK0678027T3 true DK0678027T3 (da) 2002-03-18

Family

ID=26668138

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94906461T DK0678027T3 (da) 1993-01-05 1993-12-22 Antiatherosclerotiske midler

Country Status (17)

Country Link
EP (1) EP0678027B1 (es)
JP (1) JP3344585B2 (es)
CN (1) CN1071573C (es)
AT (1) ATE209495T1 (es)
AU (1) AU6015794A (es)
CA (1) CA2152187A1 (es)
CY (1) CY2361B1 (es)
DE (1) DE69331237T2 (es)
DK (1) DK0678027T3 (es)
ES (1) ES2165382T3 (es)
HK (1) HK1011282A1 (es)
IL (1) IL108155A (es)
MX (1) MX9400254A (es)
PH (1) PH30474A (es)
PT (1) PT678027E (es)
SG (1) SG52359A1 (es)
WO (1) WO1994015612A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855703B1 (en) * 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507889A (en) * 1968-06-11 1970-04-21 American Home Prod Process for the preparation of 17alpha-dihydroequilenin and related compounds
US3608075A (en) * 1969-07-28 1971-09-21 American Home Prod Compositions and methods of treating the menopausal syndrome
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4379780A (en) * 1980-09-29 1983-04-12 American Home Products Corporation 17 α-Dihydroequilin hapten and assay method

Also Published As

Publication number Publication date
DE69331237D1 (de) 2002-01-10
HK1011282A1 (en) 1999-07-09
MX9400254A (es) 1994-08-31
ES2165382T3 (es) 2002-03-16
CY2361B1 (en) 2004-06-04
IL108155A (en) 1999-08-17
EP0678027B1 (en) 2001-11-28
EP0678027A1 (en) 1995-10-25
ATE209495T1 (de) 2001-12-15
PH30474A (en) 1997-05-28
CN1071573C (zh) 2001-09-26
WO1994015612A1 (en) 1994-07-21
AU6015794A (en) 1994-08-15
SG52359A1 (en) 1998-09-28
JP3344585B2 (ja) 2002-11-11
IL108155A0 (en) 1994-04-12
CN1096443A (zh) 1994-12-21
DE69331237T2 (de) 2002-06-13
PT678027E (pt) 2002-04-29
CA2152187A1 (en) 1994-07-21
JPH08505392A (ja) 1996-06-11

Similar Documents

Publication Publication Date Title
BR9510168A (pt) Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
DE122007000006I1 (de) Hautpflaster enthaltend Testosteron und gegebenenfalls Estrogen
CA2213339A1 (en) Method of treating adenosine depletion
NZ333380A (en) 6-O-methylerythromycin A crystal form I (clarithromycin) and preparation thereof
CA2289717A1 (en) Novel therapy for constipation
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
MY110734A (en) Improvements in or relating to dioic acids.
HK1021539A1 (en) Androstene derivatives.
UA41355C2 (uk) Засіб для лікування нейро-сніду
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
TW325996B (en) Anti-atherosclerotic composition containing 17α-dihydroequilin
CA2157142A1 (en) Treatment of diseases caused by sebaceous gland disorders
DE69424777T2 (de) 3,4-diarylchromane zur behandlung von dermatitis
ZA973444B (en) Transdermally administered dextromethorphan as antitussive agents.
MY121623A (en) Methods of preventing breast cancer.
CA2173403A1 (en) External Therapeutic Composition for Dermatitis
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
DK0678027T3 (da) Antiatherosclerotiske midler
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
FI956028A0 (fi) Estreenisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
AU5278799A (en) Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof andpharmaceutical preparations containing said compounds
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances
MY104932A (en) Immunomodulatory azaspiranes
UA41376C2 (uk) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ЛІКУВАННЯ АНДРОГЕННОЇ АЛОПЕЦІЇ ІНГІБІТОРАМИ 5-<font face="Symbol">a</font>-РЕДУКТАЗИ